Search

Your search keyword '"Massie, Barry M."' showing total 439 results

Search Constraints

Start Over You searched for: Author "Massie, Barry M." Remove constraint Author: "Massie, Barry M." Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
439 results on '"Massie, Barry M."'

Search Results

1. International differences in clinical characteristics, management, and outcomes in acute heart failure patients: better short‐term outcomes in patients enrolled in Eastern Europe and Russia in the PROTECT trial

2. Benefit of Warfarin Compared With Aspirin in Patients With Heart Failure in Sinus Rhythm

3. Predictors of early dyspnoea relief in acute heart failure and the association with 30‐day outcomes: findings from ASCEND‐HF

4. Long-Term Effect of Endothelin Receptor Antagonism With Bosentan on the Morbidity and Mortality of Patients With Severe Chronic Heart Failure: Primary Results of the ENABLE Trials

6. ACCF/AHA/HFSA 2011 Survey Results: Current Staffing Profile of Heart Failure Programs, Including Programs That Perform Heart Transplant and Mechanical Circulatory Support Device Implantation: A Report of the ACCF Heart Failure and Transplant Committee, AHA Heart Failure and Transplantation Committee, and Heart Failure Society of America

7. Effects of the Adenosine A1 Receptor Antagonist Rolofylline on Renal Function in Patients With Acute Heart Failure and Renal Dysfunction: Results From PROTECT (Placebo-Controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function)

10. Acute heart failure in elderly patients: worse outcomes and differential utility of standard prognostic variables. Insights from the PROTECT trial

17. Utility of Impedance Cardiography for the Identification of Short-Term Risk of Clinical Decompensation in Stable Patients With Chronic Heart Failure

18. Troponin I in acute decompensated heart failure: insights from the ASCEND-HF study

26. A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach

29. Abnormal liver function tests in acute heart failure: relationship with clinical characteristics and outcome in the PROTECT study

30. Patient journey after admission for acute heart failure: length of stay, 30-day readmission and 90-day mortality

31. Comparative Assessment of Short-Term Adverse Events in Acute Heart Failure With Cystatin C and Other Estimates of Renal Function: Results From the ASCEND-HF Trial

32. Worsening Heart Failure Following Admission for Acute Heart Failure: A Pooled Analysis of the PROTECT and RELAX-AHF Studies

33. Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure

34. The Aliskiren Trial to Minimize OutcomeS in Patients with HEart failure trial (ATMOSPHERE):revised statistical analysis plan and baseline characteristics

35. Effect of Beta-Blockade on Mortality in Patients With Heart Failure: A Meta-Analysis of Randomized Clinical Trials 11All editorial decisions for this article, including selection of referees, were made by a Guest Editor. This policy applies to all articles with authors from the University of California San Francisco

36. Benefit of warfarin compared with aspirin in patients with heart failure in sinus rhythm: a subgroup analysis of WARCEF, a randomized controlled trial

37. Double-blind, placebo-controlled study of the efficacy of flosequinan in patients with chronic heart failure

38. Rolofylline, an adenosine A1−receptor antagonist, in acute heart failure

40. National Heart, Lung, and Blood Institute working group on emergency department management of acute heart failure: research challenges and opportunities

41. Clinical Trials of Pharmacological Therapies in Acute Heart Failure Syndromes Lessons Learned and Directions Forward

42. Acute heart failure in elderly patients: worse outcomes and differential utility of standard prognostic variables. Insights from the PROTECT trial

43. Predictors of Postdischarge Outcomes From Information Acquired Shortly After Admission for Acute Heart Failure

44. Renal Function Trajectories and Clinical Outcomes in Acute Heart Failure

45. The relationship between left ventricular ejection fraction and mortality in patients with acute heart failure: insights from the ASCEND‐HF Trial

46. Aliskiren, ALTITUDE, and the implications for ATMOSPHERE

47. Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138 769 individuals The ARB Trialists Collaboration

49. Do Countries or Hospitals With Longer Hospital Stays for Acute Heart Failure Have Lower Readmission Rates?

Catalog

Books, media, physical & digital resources